Artwork

Content provided by Dean M. Calhoun, CIH, Affygility Solutions, and LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dean M. Calhoun, CIH, Affygility Solutions, and LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Biopharma EHS Podcast Episode No. 16

31:07
 
Share
 

Manage episode 156330782 series 1185076
Content provided by Dean M. Calhoun, CIH, Affygility Solutions, and LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dean M. Calhoun, CIH, Affygility Solutions, and LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this podcast, Dean M. Calhoun, CIH and Joe Nieusma, Ph.D. of Affygility Solutions discuss Category 4 and Category 5 Potent Compounds - Understanding the Risks.

Items covered include:

  • Review of the last podcast
  • What factors go into determining an active pharmaceutical ingredients as a Category 4 or Category 5 potent compound
  • We provide examples of Category 4 and Category 5 potent compounds
  • Review upcoming events and happenings related to environmental, health and safety in the biotechnology, pharmaceutical, and medical device industry.

If you have any questions please contact Affygility Solutions at 303-884-3028 or visit the Affygility Solutions website.

  continue reading

29 episodes

Artwork
iconShare
 
Manage episode 156330782 series 1185076
Content provided by Dean M. Calhoun, CIH, Affygility Solutions, and LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dean M. Calhoun, CIH, Affygility Solutions, and LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this podcast, Dean M. Calhoun, CIH and Joe Nieusma, Ph.D. of Affygility Solutions discuss Category 4 and Category 5 Potent Compounds - Understanding the Risks.

Items covered include:

  • Review of the last podcast
  • What factors go into determining an active pharmaceutical ingredients as a Category 4 or Category 5 potent compound
  • We provide examples of Category 4 and Category 5 potent compounds
  • Review upcoming events and happenings related to environmental, health and safety in the biotechnology, pharmaceutical, and medical device industry.

If you have any questions please contact Affygility Solutions at 303-884-3028 or visit the Affygility Solutions website.

  continue reading

29 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide